Tumor-Selective Response to Antibody-Mediated Targeting of αvβ3 Integrin in Ovarian Cancer

NEOPLASIA

NEOPLASIA PRESS

1. Reproductive Scientist Development Program [K12 HD00849]
2. Department of Defense [W81XWH-04-1-0227]
3. University of Texas MD Anderson Cancer Center Specialized Program of Research Excellence [CA083639]
4. National Institutes of Health [CA10929801, CA11079301]
5. Ovarian Cancer Research Fund, Inc.
6. Marcus Foundation